Studies in our laboratory, however, have recently found that Fasudil treatment commencing three days after stroke indeed modulates reactive gliosis to reduce glial scarring in rats, as evidenced by reduced GFAP staining and the adoption of less reactive morphologies up to 28 days (Figure 5B) [128] (unpublished data). The gene discussed is GFAP; the disease is Stroke.